Tag: diabetes drugs
-
Pancreatic Cancer Associated With Use Of Diabetes Medicines In DPP-4 Inhibitor Drug Class
Increased Risk For Patients With Newly Diagnosed Type 2 Diabetes According To Recent Medical Research Study (Posted by Tom Lamb at DrugInjuryWatch.com) Use of dipeptidyl peptidase-4 inhibitors (DPP-4i) diabetes medicines is associated…
-
Fournier’s Gangrene Is A Side Effect Of Farxiga, Invokana, Jardiance, And Other SGLT2 Inhibitor Diabetes Drugs — Or Is It?
At The Recent American Diabetes Association (ADA) Scientific Sessions There Was An Expression Of Doubt About Warnings For This Association (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2018 the FDA required…
-
Januvia, Onglyza, Other Diabetes Drugs In DPP-4 Inhibitor Class Significantly Increase Risk Of Crohn’s Disease (CD)
But Same Medical Study Finds That DPP-4 Inhibitors Do Not Increase Risk Of Inflammatory Bowel Disease (IBD) (Posted by Tom Lamb at DrugInjuryWatch.com) Back in March 2018 we wrote this report, “Januvia,…
-
There Is A Warning About Increased Risk Of Lower Limb Amputations For Invokana And Invokamet (Only)
Going Into 2019 The Issue Of These Amputations Being An SGLT2 Inhibitors Drug Class Side Effect Remains Open To Debate (Posted by Tom Lamb at DrugInjuryWatch.com) A year-and-a-half ago we wrote this…
-
Diabetes Drugs In DPP-4 Inhibitor Class Associated With Almost Two-Times Increased Risk Of Cholangiocarcinoma
Medical Researchers Finding This Rare But Highly Fatal Cancer Call For More Investigation Into New Possible Drug Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) A recent medical study shows that the…
-
Farxiga And Jardiance Are Associated With Twofold Increased Risk For Lower Limb Amputations
November 2018: The BMJ Medical Journal Publishes New SGLT2 Diabetes Drug Observational Study (Posted by Tom Lamb at DrugInjuryWatch.com) Diabetes drugs in the sodium-glucose cotransporter 2 (SGLT2) inhibitors class are associated with…
-
Amputations Side Effects: Invokana Only, Or Jardiance, Farxiga, And Other SGLT2 Inhibitors Diabetes Drugs, Too?
Increasing Degree Of Acknowledgement In Medical Literature That Toe, Foot, And Leg Amputations Are Drug-Class Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) We have been following developments in the medical realm…
-
Amputations Are SGLT-2 Inhibitors Drug-Class Side Effects It Now Appears, According To New Medical Evidence
Earlier Invokana Lower Limb Amputation Reports Are Being Followed By Farxiga And Jardiance Amputation Cases Now (Posted by Tom Lamb at DrugInjuryWatch.com) There is new medical evidence which suggests the hypovolemic effect…
-
Newer Diabetes Drugs Side Effect: Fournier’s Gangrene, Serious Infection Of Genital Area
FDA Mandates Label Changes With New Warnings For Invokana, Farxiga, Jardiance, Other SGLT2 Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) In late August 2018 the FDA warned doctors and patients that cases…
-
Invokana / Jardiance / Farxiga: Increased Risks Of Lower-Limb Amputations Compared To Another Class Of Diabetes Drugs
Today Only The Invokana Drug Label Includes Warnings About Amputations Of Legs, Feet, And Toes; Will There Be Label Changes For Farxiga And Jardiance? (Posted by Tom Lamb at DrugInjuryWatch.com) Another new…